Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease
PHASE4CompletedINTERVENTIONAL
Enrollment
66
Participants
Timeline
Start Date
November 30, 2013
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
Conditions
Type 2 DiabetesCoronary Artery DiseaseLeft Ventricular Mass
Interventions
DRUG
alpha-lipoic acid
Trial Locations (1)
430070
Wuhan General Hospital, Wuhan
All Listed Sponsors
lead
Wuhan General Hospital of Guangzhou Military Command
OTHER
NCT01877590 - Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease | Biotech Hunter | Biotech Hunter